We are live on ! Find out more
OCGN icon

Ocugen

20 hedge funds and large institutions have $21.4M invested in Ocugen in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

2.66% less ownership

Funds ownership: 50.8% → 48.14% (-2.7%)

9% less funds holding

Funds holding: 22 → 20 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

68% less capital inflows, than outflows

Capital inflows: $375K | Capital outflows: $1.19M

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
3
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

OCGN Hedge Fund Activity: Q3 2017 in Review

20 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q3 2017, worth a combined $21.4M — up 6.2% from $20.2M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of OCGN and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $138K. The largest seller was Sabby Management, cutting an estimated $1.13M.

  • 20 institutional investors held Ocugen (OCGN) as of Q3 2017, down from 22 in Q2 2017.
  • Funds reported $21.4M of Ocugen stock for Q3 2017, up 6.2% quarter-over-quarter.
  • 3 funds opened new Ocugen positions in Q3 2017 and 5 closed out, a net change of -2 holders.
  • The largest Ocugen buyer in Q3 2017 was Renaissance Technologies, an estimated $138K added.
  • The largest Ocugen seller in Q3 2017 was Sabby Management, an estimated $1.13M sold.

Based on aggregated 13F filings for Q3 2017.